Bragg Financial Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.32M Buy
4,503
+3
+0.1% +$986 0.04% 202
2025
Q4
$1.58M Hold
4,500
0.05% 196
2025
Q3
$1.45M Sell
4,500
-31
-0.7% -$9.64K 0.05% 193
2025
Q2
$1.76M Buy
4,531
+13
+0.3% +$5.23K 0.06% 190
2025
Q1
$1.97M Hold
4,518
0.08% 173
2024
Q4
$1.67M Hold
4,518
0.07% 182
2024
Q3
$2.35M Sell
4,518
-48
-1% -$25.6K 0.1% 165
2024
Q2
$2.47M Sell
4,566
-10
-0.2% -$5.29K 0.11% 153
2024
Q1
$2.37M Sell
4,576
-20
-0.4% -$9.95K 0.11% 157
2023
Q4
$2.17M Hold
4,596
0.1% 158
2023
Q3
$2M Buy
4,596
+66
+1% +$29.9K 0.11% 163
2023
Q2
$2.01M Hold
4,530
0.11% 158
2023
Q1
$2.08M Hold
4,530
0.12% 158
2022
Q4
$2.32M Hold
4,530
0.14% 154
2022
Q3
$2.06M Hold
4,530
0.14% 150
2022
Q2
$2.19M Hold
4,530
0.15% 144
2022
Q1
$2.23M Sell
4,530
-1,802
-28% -$824K 0.13% 147
2021
Q4
$2.36M Hold
6,332
0.15% 139
2021
Q3
$2.36M Buy
6,332
+32
+0.5% +$12.2K 0.15% 139
2021
Q2
$2.4M Hold
6,300
0.15% 139
2021
Q1
$2.26M Hold
6,300
0.15% 136
2020
Q4
$2.02M Hold
6,300
0.18% 133
2020
Q3
$1.69M Sell
6,300
-26
-0.4% -$7K 0.17% 132
2020
Q2
$1.66M Sell
6,326
-1,006
-14% -$268K 0.19% 131
2020
Q1
$1.67M Sell
7,332
-23
-0.3% -$6.27K 0.22% 126
2019
Q4
$2.22M Hold
7,355
0.25% 123
2019
Q3
$1.77M Buy
7,355
+14
+0.2% +$3.84K 0.21% 133
2019
Q2
$2.07M Buy
7,341
+28
+0.4% +$7.65K 0.26% 125
2019
Q1
$2.1M Buy
7,313
+13
+0.2% +$3.76K 0.27% 120
2018
Q4
$1.92M Hold
7,300
0.29% 117
2018
Q3
$2M Sell
7,300
-40
-0.5% -$10.4K 0.27% 118
2018
Q2
$1.75M Hold
7,340
0.25% 125
2018
Q1
$1.61M Hold
7,340
0.24% 131
2017
Q4
$1.65M Hold
7,340
0.24% 129
2017
Q3
$1.39M Hold
7,340
0.21% 145
2017
Q2
$1.38M Hold
7,340
0.22% 142
2017
Q1
$1.21M Hold
7,340
0.19% 147
2016
Q4
$1.05M Hold
7,340
0.17% 162
2016
Q3
$920K Hold
7,340
0.16% 165
2016
Q2
$964K Sell
7,340
-8
-0.1% -$1.09K 0.17% 162
2016
Q1
$1.02M Buy
7,348
+3,048
+71% +$407K 0.2% 157
2015
Q4
$600K Hold
4,300
0.13% 173
2015
Q3
$602K Hold
4,300
0.14% 165
2015
Q2
$706K Hold
4,300
0.16% 163
2015
Q1
$664K Hold
4,300
0.15% 162
2014
Q4
$553K Buy
+4,300
New +$531K 0.13% 170
2014
Q3
Sell
-4,300
Closed -$463K 224
2014
Q2
$463K Hold
4,300
0.11% 185
2014
Q1
$428K Hold
4,300
0.1% 186
2013
Q4
$397K Buy
+4,300
New +$382K 0.1% 196

Other funds holding ELV

Bragg Financial Advisors's ELV Position: Q1 2026 in Review

Bragg Financial Advisors increased its Elevance Health (ELV) stake by 0.07% in Q1 2026, buying an estimated $986 and bringing the position to 4,503 shares worth $1.32M. The position accounts for 0.04% of the portfolio, ranked #202.

Bragg Financial Advisors first reported a position in ELV in Q4 2013 and has held it in 49 quarters since. The position peaked at $2.47M in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Bragg Financial Advisors held 4,503 shares of Elevance Health worth $1.32M as of Q1 2026.
  • Bragg Financial Advisors bought 3 Elevance Health shares in Q1 2026, an estimated $986.
  • Elevance Health made up 0.04% of Bragg Financial Advisors's portfolio in Q1 2026, its #202 holding.
  • Bragg Financial Advisors first reported a position in Elevance Health in Q4 2013 and has held it in 49 quarters since.
  • Bragg Financial Advisors's Elevance Health position peaked at $2.47M in Q2 2024.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Bragg Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.